Publication | Open Access
Developing Allogeneic Double-Negative T Cells as a Novel Off-the-Shelf Adoptive Cellular Therapy for Cancer
65
Citations
38
References
2019
Year
We have established a method to generate therapeutic numbers of clinical-grade DNTs that fulfill the requirements of an off-the-shelf ACT.
| Year | Citations | |
|---|---|---|
Page 1
Page 1